Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies
Stopped Considering new technology for product.
Conditions
- Acute Lymphoblastic Leukemia
- Burkitt Lymphoma
- Natural Killer Cell Malignancies
- Chronic Myelogenous Leukemia
- Myelodysplastic Syndromes
- Large-cell Lymphoma
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Marginal Zone B-Cell Lymphoma
- Follicular Lymphoma
- Lymphoplasmacytic Lymphoma
- Mantle-Cell Lymphoma
- Prolymphocytic Leukemia
- Hodgkin Lymphoma
- Multiple Myeloma
- Acute Myelogenous Leukemia
- Biphenotypic Leukemia
- Undifferentiated Leukemia
Interventions
- BIOLOGICAL: Infusion of Treg
Sponsor
Masonic Cancer Center, University of Minnesota